FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Bracco Diagnostics multihance Recall

Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx o…

Bracco Diagnostics Inc · Monroe Township, NJ

Risk level
Class III
Reported by FDA
Sep 5, 2012
Recall ID
D-1663-2012
Check your lot numberHow we source this data

Summary

Bracco Diagnostics recalled Bracco Diagnostics multihance starting Apr 16, 2012. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1663-2012 on Sep 5, 2012. Reason: Short Fill: The product is being recalled due to a potential underfill of the affected vials. Status: Terminated.

Why it was recalled

Short Fill: The product is being recalled due to a potential underfill of the affected vials.

Product description

Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15

Lot numbers, UPCs & expiration codes

Lot S1P272A Expiry Date: December 2014

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1663-2012
Classification
Class III
Status
Terminated
Recall initiated
Apr 16, 2012
FDA report date
Sep 5, 2012
Quantity
47,750 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Bracco Diagnostics Inc

Original FDA data

Every field from FDA enforcement report D-1663-2012, exactly as published.

Show all FDA fields
City
Monroe Township
State
NJ
Status
Terminated
Country
United States
Event ID
62636
Address
259 Prospect Plains Rd.
Address (line 2)
Building H
Code information
Lot S1P272A Expiry Date: December 2014
Postal code
08831
Report date
Sep 5, 2012
Product type
Drugs
Recall number
D-1663-2012
Classification
Class III
Recalling firm
Bracco Diagnostics Inc
Product quantity
47,750 vials
Termination date
Jul 8, 2013
Reason for recall
Short Fill: The product is being recalled due to a potential underfill of the affected vials.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15
Distribution pattern
Nationwide
Recall initiation date
Apr 16, 2012
Initial firm notification
Letter
Center classification date
Aug 27, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1663-2012, published Sep 5, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls